INTRODUCTION
with 100 ng trypsin at 37°C. The resulting peptide digests were then analyzed with LC-MS/MS (QSTAR ® Pulsar XL QqTOF-MS; LC Packings and Applied Biosystems, Sunnyvale, CA, USA) on an LC Packings PepMap C18 pre-column and C18 analytical column. For 2-DE/MS experiments, saliva proteins were sequentially separated by isoelectric focusing and SDS-PAGE, and were visualized with Sypro-Ruby (Molecular Probes, Eugene, OR, USA). Gel spots were then excised and digested for MALDI-MS analysis (Micromass-Waters, Beverly, MA, USA), with ␣-cyano-4-hydroxycinnamic acid as the matrix. Database searching was performed with Mascot software (Matrix Science, London, UK).
RNA Isolation, Amplification, and HG-U133A Microarray Analysis
RNA was isolated from saliva supernatant with the use of a QIAamp Viral RNA kit (Qiagen, Valencia, CA, USA) as previously reported (Li et al., 2004a) . Aliquots of RNA were treated with RNase-free DNase (DNase I-DNA-free, Ambion Inc., Austin, TX, USA) and then subjected to linear amplification in a RiboAmp TM RNA Amplification kit (Arcturus, Mountain View, CA, USA). We then used the Human Genome U133A Array (Affymetrix, Santa Clara, CA, USA) to perform gene expression analysis. The arrays were scanned, and the fluorescence intensities were measured by Microarray Suite 5.0 software (Affymetrix) . The data were imported into DNA-Chip Analyzer software (Affymetrix) for normalization and model-based analysis (Li and Wong, 2001) . A detection p-value was obtained for each probe set, and any probe sets with p < 0.04 were assigned as "present", indicating that the matching gene transcript was reliably detected (Affymetrix, 2001) . The raw data were then exported to Microsoft Excel software for data-sorting and -mining.
RT-PCR
We performed RT-PCR to validate a subset of selected transcripts that were assigned as "absent" on all 10 microarrays. Total RNA was reverse-transcribed in 40 L of reaction mixture containing 2.5 U of Moloney murine leukemia virus reverse transcriptase and 50 pmol of random hexanucleotides (Applied Biosystems Inc.) at 42°C for 45 min. Oligonucleotide primers for PCR were obtained from Fisher Scientific (Tustin, CA, USA) (Table) . Amplification of the complementary DNA (cDNA) was carried out by 50 cycles at 95°C for 20 sec, customized annealing Tm for 30 sec, and at 72°C for 30 sec, followed by a final extension cycle at 72°C for 7 min. Specificity of the PCR products was verified by the predicted size and by restriction digestion. To establish the specificity of the responses, we used negative controls in which either input RNA or the reverse transcriptase was omitted. As a positive control, mRNA was extracted from total salivary gland RNA (Clontech, Palo Alto, CA, USA).
RESULTS

Analysis of Salivary Proteomes and Transcriptomes
Using proteomics profiling, we have identified 309 saliva proteins from a healthy participant (Participant 1), including 220 proteins with known biological functions (Hu et al., 2004 (Hu et al., , 2005 . A 2-D virtual display (pI vs. Mr) illustrates the isoelectric point and molecularweight distributions of all identified saliva proteins (pI 4.4-12.1; Mr 2.9-590 kDa) ( Fig.  1A) . Such a virtual gel can allow for the location of saliva proteins of interest on a real 2-D electrophoresis gel. Recently, we have conducted the proteome analysis of saliva samples from two additional healthy volunteers. In total, we have identified 282 (213 functionknown) and 297 (229 function-known) distinct saliva proteins from Participants 2 and 3, respectively. Saliva mRNA profiles of the same three participants were obtained with the use of HG U133A expression arrays, which contain 22,215 human gene cDNA probe sets, representing 1 9,000 genes. For the three participants, 3160, 2698, and 3638 probe sets (p < 0.04) on the array were assigned as present, indicating that 2940, 2521, and 3363 saliva mRNAs, respectively, were reliably detected.
Normal Saliva Core Transcriptome (NSCT)
We have profiled the saliva mRNA of 10 normal individuals using the U133A arrays. On average, 3143 ± 665 probe sets (p < 0.04, n = 10) were assigned as present (Li et al., 2004a) . Two hundred seven probe sets, representing 185 genes, were detected among all 10 participants (detection p < 0.01).
Using the same criterion, we found 570 genes present in 8/10 (80%) arrays, and 417 genes in 9/10 (90%) arrays. Among these, 49 and 37 salivary mRNAs, respectively, were found to be present in saliva at protein levels as determined by proteomic approaches. The genes present among all 10 arrays (100%) are referred to as "Normal Saliva Core Transcriptome (NSCT)" (APPENDIX). Their nucleotide sequences were virtually translated into amino acid sequences, and then the corresponding pI and molecular weights were displayed in a virtual 2-D format (Fig. 1B) . These core genes were evenly distributed across a wide pI range (pI 3.7-12.1), but their Mr fell into a relatively narrow range, from around 10 to 100 kDa. Of the 185 core mRNAs, 43 (23%, highlighted in the APPENDIX) were also found present at the protein level in the 3 saliva samples examined by proteomics approaches.
Co-existence of Saliva Protein and mRNA
The saliva protein and mRNA lists obtained from the three participants' saliva were compared, and a co-existence phenomenon was observed. In Participant 1, 309 saliva proteins were identified, including 220 proteins with known biological functions and 89 hypothetical proteins without annotated function. Microarray profiling indicated that 154 (154/220, 70%) proteins with known functions were detected at the mRNA level, and the remaining 66 were not detectable. Similarly, 61% (130/213) and 65% (149/229) of functionknown saliva proteins identified in Participants 2 and 3, respectively, were also found to "co-exist" with their saliva mRNAs.
Because microarray profiling may give false-negative results pertaining to the detected absence of saliva mRNA, we proceeded to test if the "undetectable" mRNAs were actually absent or present in saliva. We used RT-PCR to validate the presence of 9 mRNAs randomly selected from the "undetectable" 66 mRNAs from Participant 1. These mRNAs included serum albumin (ALB), heat-shock 60-kDa protein 1 (HSPD1), defensin, alpha-3 (DEFA3), neutrophil defensin 3 (HNP-3), integrin, beta 6 (ITGB6), kallikrein 1 (KLK1), ribosomal protein S11 (RPS11), transferrin (TF), and zincalpha-2-glycoprotein precursor (LOC340333) ( Table) . RT-PCR results indicated that mRNAs of HSPD1, DEFA3, ITGB6, KLK1, RPS11, TF, and HNP-3 were actually present in the saliva from Participant 1, and that LOC340333 and ALB mRNAs were undetectable (Fig. 2) . These results suggested that the co-existence of salivary proteins and their mRNAs may reach a higher extent than the 70% (154/220) obtained by comparison of the proteomics and microarray outcomes. Of the remaining 66 (30%) salivary mRNAs that were undetectable by microarray, 7/9 (78%) could be independently detected by RT-PCR. This suggested that ~ 51 (78% of 66) additional saliva proteins may have a corresponding mRNA co-existing in saliva. Therefore, we may predict a co-existence rate of 93% (205/220) for saliva proteins and their counterpart saliva mRNAs. Similarly, we were able to validate 3 out of 5 randomly selected genes initially undetectable by microarray profiling in Participant 2 or Participant 3. RT-PCR analysis indicated that mRNAs of transcobalamin I (TCN1), myeloperoxidase (MPO), and hemopexin (HPX) were actually present in the saliva from Participant 2, whereas hepatocellular carcinoma-associated protein TB6 (PIGR) and alpha-1antitrypsin (SERPINA1) mRNAs were undetectable. Meanwhile, in Participant 3, cystatin SA (CYST2), carbonic anhydrase IV (CA4), and HPX were detected, whereas cystatin SN (CYST1) and SERPINA1 were not (Figs. 2B, 2C ).
DISCUSSION
The correlative analysis of saliva proteome and transcriptome is meaningful only when the comparison is performed within the same individual. Within all three participants examined, certain concordance was observed between saliva proteomes and transcriptomes, as revealed by proteomic and microarray profiling. In Participant 1, 70% (154/220) of the functionknown proteins identified in saliva were found present as mRNA transcripts. This may fluctuate somehow, due to incompatible gene names or accession numbers, but it indicates the co-existence phenomenon between saliva proteins and mRNAs. Complementarity was obvious for common saliva proteins (such as statherin, histatins, cystatins, and proline-rich proteins), saliva enzymes (such as lysozyme, amylase, lactate dehydrogenase, and cytochrome c oxidase), and structural proteins (such as actins, tubulins, and keratins). Both proteome and transcriptome profiling revealed a similar percentage of function-unknown genes (28.7% and 27.5%, respectively). Correlation of these function-unknown genes at protein and RNA levels is difficult, due to the lack of their annotation in the databases. Similarly, 61% (130/213) and 65% (149/229) of function-known proteins identified in saliva from Participants 2 and 3 were found present as mRNA transcripts, as revealed by microarray profiling. This might have been underestimated, because, as suggested by the RT-PCR study, microarray profiling may miscall the absence of those remaining mRNAs. While it is highly desirable to analyze the salivary proteome of additional healthy individuals (e.g., 10), the current limited throughput of proteomics technologies renders this goal impractical. Typically, it takes several months to complete the analysis of an individual's saliva proteome, even with state-ofthe-art proteomics technologies. However, through the comparative analyses of three pairs of saliva proteomes and transcriptomes, we achieved a consistent outcome that allowed us to estimate conclusively the correlation between saliva proteins and mRNAs.
Many genes were found only at either the protein or the mRNA level. For instance, proteomics revealed all salivary cystatin isoforms; however, microarray detected only 2 mRNAs from this gene family. This may be simply because there are no matching probe sets on the U133A array for other cystatins. Conversely, microarray revealed many ribosomal mRNAs, while proteomics discovered only some of the ribosomal proteins. It is likely that our preliminary MS analysis yielded only a subset of the entire saliva proteome. An additional prefractionation strategy can help expand the catalogue of saliva proteins. Currently, for a specific gene, validation at either the protein or the mRNA level is required for accurate RNA-protein correlation analysis.
In Participant 1, our analysis indicated that 70% (154/220) of the function-known saliva proteins had a corresponding saliva mRNA detectable by microarray. Of the remaining 66 (30%) genes, 9 candidates were selected for detection of the corresponding mRNA by RT-PCR (Table) . These mRNA candidates were not found by microarray profiling, possibly because of the absence of matching probe sets on the U133A array. Seven of 9 genes were detectable by RT-PCR in saliva from Participant 1 ( Fig. 2A ), suggesting a higher correlation between saliva mRNAs and proteins than we obtained from proteomics and microarray profiling. Of the remaining 66 (30%) salivary mRNAs that were undetectable by microarray, 7/9 (78%) could be independently detected by RT-PCR. This suggests that ~ 51 (78% of 66) additional saliva proteins actually have a corresponding mRNA co-existing in saliva, and predicts a co-existence rate of 93% (205/220) for saliva proteins and their counterpart mRNAs. Similarly, further RT-PCR analysis suggested that there was a higher co-existence rate (85% for Participant 2 and 86% for Participant 3) than the one obtained from direct correlation of proteomics and microarray data (61% for Participant 2 and 65% for Participant 3).
The proteins discovered by proteomics represent only a partial list of all proteins in whole saliva. Many saliva proteins at lower concentrations remain to be identified. Therefore, only 7% of saliva mRNAs detected by microarray profiling were found to be present in the protein list. But this does not necessarily mean that the remaining (93%) mRNAs lack counterpart proteins. Several genes-including calmodulin, ␤-2-microglobulin, epidermal growth factor, ferritin, fibroblast growth factor, heat-shock protein 70, hepatocyte growth factor, histones, interleukin-2, interleukin-6, interleukin-8, superoxide dismutase, etc.-were detected by microarray, but not by proteomic profiling. Other investigators have previously found these proteins to be present in human saliva (Balekjian and Longton, 1973; Law and Henkin, 1986; Maddali et al., 1995; Trubnikov et al., 1998; Kagami et al., 2000; Streckfus et al., 2001; Nagler et al., 2002; Ohshima et al., 2002; Fabian et al., 2003; Eckley et al., 2004) . In conclusion, comparative analysis of the saliva proteome and transcriptome from three healthy individuals allowed us to conclude that many salivary proteins and mRNA are concordantly present in human saliva. This is an important observation, since we, and others, are actively deciphering the human salivary proteome. One of the problems inherent in saliva proteome analysis is how to define the boundary of the proteome and decide the 'finish line' for the analysis. Considering the relatively high co-existence rate for saliva proteins and their counterpart mRNAs, the salivary transcriptome may serve as a good indicator of the diversity and range of the salivary proteome, and can be used as a reference guideline for human saliva proteome analysis. The specificity and coverage of RNA and protein profiling technologies need to be improved to yield more accurate and complete RNA-protein correlation analysis. In addition to highthroughput MS and microarray profiling, complementary validation methods, such as Western blots/ELISA or RT-PCR, will be required in the conduct of RNA-protein correlation studies.
